Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulonga-4 granules for acute infectious diarrhea (Phase IIa, randomized open-label study)
CTR20251279Phase 2Active
- Sponsor
- Inner Mongolia International Mongolian Medicine Hospital
- Start
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Sulonga-4 granules in acute diarrhea, sponsored by Inner Mongolia International Mongolian Medicine Hospital. Started May 2025; status: active.
02
Drugs
Sulonga-4 granules
03
Conditions
acute diarrhea
Beyond the preview
Go deeper on CTR20251279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251279.